You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

recurrent neuroblastoma

Showing 1 - 25 of 8,176
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuroblastoma Trial in Lille, Lyon, Toulouse (PRRT with 177Lu-DOTATATE)

Not yet recruiting
  • Neuroblastoma
  • PRRT with 177Lu-DOTATATE
  • Lille, France
  • +2 more
Nov 8, 2022

Recurrent Neuroblastoma Trial in Germany (metronomic therapy)

Recruiting
  • Recurrent Neuroblastoma
  • metronomic therapy
  • Bonn, Germany
  • +7 more
Nov 3, 2022

Recurrent Neuroblastoma, Neuroblastoma Trial in Oklahoma City, Dallas, Fort Worth (Fenretinide Lym-X-Sorb Oral Powder,

No longer available
  • Recurrent Neuroblastoma
  • Neuroblastoma
  • Oklahoma City, Oklahoma
  • +2 more
Mar 17, 2022

Neuroblastoma, Solid Tumor Trial (APG-115, APG-2575)

Not yet recruiting
  • Neuroblastoma
  • Solid Tumor
  • (no location specified)
Jan 18, 2023

Neuroblastoma, Diffuse Intrinsic Pontine Glioma Trial in Gainesville, Charlotte (Tumor-specific ex vivo expanded autologous

Recruiting
  • Neuroblastoma
  • Diffuse Intrinsic Pontine Glioma
  • Tumor-specific ex vivo expanded autologous lymphocyte transfer (TTRNA-xALT)
  • Gainesville, Florida
  • +1 more
Apr 20, 2022

Recurrent Neuroblastoma, Recurrent Osteosarcoma, Refractory Neuroblastoma Trial in Bethesda, Seattle, Madison (Cyclophosphamide,

Recruiting
  • Recurrent Neuroblastoma
  • +3 more
  • Palo Alto, California
  • +3 more
Jan 25, 2023

Neuroblastoma, Effects of Immunotherapy Trial in Guangzhou (Anti-GD2 CART)

Suspended
  • Neuroblastoma
  • Effects of Immunotherapy
  • Anti-GD2 CART
  • Guangzhou, Guangdong, China
    Zhujiang Hospital of Southern Medical University
Aug 2, 2021

Neuroblastoma Recurrent Trial in Hong Kong (Natural killer cell, Dinutuximab beta, Interleukin-2)

Recruiting
  • Neuroblastoma Recurrent
  • Natural killer cell
  • +4 more
  • Hong Kong, Hong Kong
    Hong Kong Children's Hospital
Feb 22, 2023

High Risk Neuroblastoma, Recurrent Neuroblastoma, Recurrent Osteosarcoma Trial in Canada, United States (Dinutuximab,

Recruiting
  • High Risk Neuroblastoma
  • +4 more
  • Biospecimen Collection
  • +6 more
  • Los Angeles, California
  • +10 more
Jan 19, 2023

Neuroblastoma Trial in Cologne (antibody ch14.18, GM-CSF, IL-2 i.v.)

Terminated
  • Neuroblastoma
  • antibody ch14.18
  • +4 more
  • Cologne, Germany
    University of Cologne
Nov 3, 2022

Olfactory Neuroblastoma, Esthesioneuroblastoma, Tumor of the Nasal Cavity Trial run by the NCI (Bintrafusp alfa / M7824)

Recruiting
  • Olfactory Neuroblastoma
  • +2 more
  • Bintrafusp alfa / M7824
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 6, 2022

Solid Tumors, Neuroblastoma, Rhabdomyosarcoma Trial in Durham, Cincinnati (VAL-413, Temozolomide)

Recruiting
  • Solid Tumors
  • +5 more
  • Durham, North Carolina
  • +2 more
Jan 31, 2023

Recurrent Solid Tumor, Recurrent Ewing Sarcoma, Recurrent Hepatoblastoma Trial in Canada, United States (Onivyde, Talazoparib,

Recruiting
  • Recurrent Solid Tumor
  • +21 more
  • Palo Alto, California
  • +8 more
Jun 7, 2022

Neuroblastoma, Medulloblastoma Trial in United States (TPI 287)

Terminated
Has Results
  • Neuroblastoma
  • Medulloblastoma
  • TPI 287
  • San Diego, California
  • +7 more
Apr 20, 2022

Refractory or Recurrent Neuroblastoma in Children Trial (Anlotinib and irinotecan combined with temozolomide)

Not yet recruiting
  • Refractory or Recurrent Neuroblastoma in Children
  • Anlotinib and irinotecan combined with temozolomide
  • (no location specified)
Apr 12, 2021

Neuroblastoma Recurrent Trial in Worldwide (Naxitamab and GM-CSF in combination with irinotecan and temozolomide)

Terminated
  • Neuroblastoma Recurrent
  • Naxitamab and GM-CSF in combination with irinotecan and temozolomide
  • Hong Kong, Hong Kong
  • +2 more
Nov 8, 2022

Metastatic Melanoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Hodgkin Lymphoma Trial in

Active, not recruiting
Has Results
  • Metastatic Melanoma
  • +22 more
  • Ipilimumab
  • +3 more
  • Birmingham, Alabama
  • +24 more
Jan 19, 2023

Neuroblastoma, Neuroblastoma Recurrent, GD2-positive Solid Tumors Trial in Roma (GD2-CART01)

Recruiting
  • Neuroblastoma
  • +5 more
  • GD2-CART01
  • Roma, Italy
    Ospedale Pediatrico Bambino Gesù
Mar 9, 2022

Constitutional Mismatch Repair Deficiency Syndrome, Hematopoietic and Lymphoid Cell Tumor, Lynch Syndrome Trial in Canada,

Withdrawn
  • Constitutional Mismatch Repair Deficiency Syndrome
  • +11 more
  • Biospecimen Collection
  • +2 more
  • Palo Alto, California
  • +8 more
Sep 9, 2022

Neuroblastoma Trial (Apatinib, Irinotecan, Temozolomide)

Not yet recruiting
  • Neuroblastoma
  • Apatinib, Irinotecan, Temozolomide
  • (no location specified)
Aug 29, 2021

Desmoplastic Small Round Cell Tumor, Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Desmoplastic Small

Recruiting
  • Desmoplastic Small Round Cell Tumor
  • +11 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 26, 2022

Refractory Cancer, CNS Tumors, CNS Tumor, Adult Trial in Atlanta, New York (Avutometinib)

Recruiting
  • Refractory Cancer
  • +14 more
  • Atlanta, Georgia
  • +1 more
Oct 23, 2023

CNS Embryonal Tumor With Rhabdoid Features, CNS Embryonal Tumor, Not Otherwise Specified, CNS Ganglioneuroblastoma Trial in

Active, not recruiting
Has Results
  • Central Nervous System Embryonal Tumor With Rhabdoid Features
  • +14 more
  • Birmingham, Alabama
  • +23 more
Oct 7, 2022

Neuroblastoma, Neuroectodermal Tumors, Tumors Trial in United States (131I-MIBG, 131-MIBG + Vorinostat)

Recruiting
  • Neuroblastoma
  • +2 more
  • San Francisco, California
  • +15 more
Jan 7, 2022

Colorectal Carcinoma, Endometrial Carcinoma, Melanoma Trial in United States (Tegavivint)

Recruiting
  • Colorectal Carcinoma
  • +21 more
  • Dual X-ray Absorptiometry
  • +2 more
  • Birmingham, Alabama
  • +18 more
Jan 30, 2023